...
首页> 外文期刊>European journal of clinical pharmacology >Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.
【24h】

Early modifications of fatty acid composition in plasma phospholipids, platelets and mononucleates of healthy volunteers after low doses of n-3 polyunsaturated fatty acids.

机译:低剂量的n-3多不饱和脂肪酸后,健康志愿者血浆磷脂,血小板和单核中脂肪酸组成的早期修饰。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVES: Although previous data suggested that only doses of 4 g/day or higher of n-3 polyunsaturated fatty acids (PUFA) have had a beneficial effect in the prevention of atherosclerosis and cardiovascular diseases, the GISSI-Prevenzione Study in a 3-year trial showed that 1 g/day reduced total and cardiovascular mortality in over 11,000 post-infarction patients. The aim of this study was to investigate the time course and the extent of incorporation of n-3 fatty acids in plasma and blood cells after 1 g/day of n-3 PUFA, the dose effective in the GISSI-Prevenzione in comparison with higher doses. METHODS: Thirty-six healthy volunteers were given 1, 2 and 4 g/day of n-3 PUFA ethyl esters for 12 weeks, followed by a 4-week washout. Blood was collected at weeks 0, 1, 2, 4, 8, 12 and 16 and used for lipid profile analysis and measurement of fatty acid composition in plasma phospholipids, platelets and mononucleates. RESULTS: Total n-3 PUFA increased by 2.0-, 2.2- and 2.9-fold versus baseline after 12-week treatment with 1, 2 and 4 g respectively. A statistically significant raise of total n-3 PUFA was seen in platelets and mononucleates. Among individual n-3 PUFA, 22:5 n-3 was enriched early and dose dependently in plasma phospholipids, platelets and mononucleates; the raise of 22:6 n-3 was less marked especially in platelets and mononucleates. CONCLUSIONS: One gram per day of n-3 PUFA induces fast (within 1 week) and striking changes in blood composition of PUFA that may well explain their beneficial effects against cardiovascular diseases.
机译:目的:尽管以前的数据表明,每天仅4 g /天或更高剂量的n-3多不饱和脂肪酸(PUFA)对预防动脉粥样硬化和心血管疾病具有有益的作用,但是GISSI-Prevenzione进行了为期3年的研究试验显示,每天1 g的药物可降低11,000多名梗死后患者的总死亡率和心血管死亡率。这项研究的目的是研究1 g /天n-3 PUFA后血浆和血细胞中n-3脂肪酸掺入的时程和程度,与更高剂量相比,在GISSI-Prevenzione中的有效剂量剂量。方法:36名健康志愿者每天接受1、2和4克/天的n-3 PUFA乙酯治疗12周,然后进行4周冲洗。在第0、1、2、4、8、12和16周收集血液,用于血脂分析和血浆磷脂,血小板和单核中脂肪酸组成的测量。结果:在分别用1、2和4 g治疗12周后,总n-3 PUFA较基线增加了2.0倍,2.2倍和2.9倍。血小板和单核细胞中总n-3 PUFA的增加具有统计学意义。在个体n-3 PUFA中,血浆磷脂,血小板和单核中22:5 n-3早期富集,并呈剂量依赖性。 22:6 n-3的升高较少,特别是在血小板和单核细胞中。结论:每天1克n-3 PUFA可以快速(在1周内)引起PUFA血液成分的惊人变化,这可以很好地解释其对心血管疾病的有益作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号